The candidates in form of synthesized peptides or peptides expressing mRNAs were used to stimulate specific CD8+ T cells in vitro for T cell adoptive therapy or in vivo for tumor vaccine therapy [3, 5, 6]. The gene discussed is CD8A; the disease is neoplasm.